The role of depth of response and single-nucleotide polymorphisms as a prediction of the efficacy for third line chemotherapy in metastatic colorectal cancer. This is an ASCO Meeting Abstract from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback